Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis

Haiming Chen, Richard A. Campbell, Yunchao Chang, Mingjie Li, Cathy S. Wang, Jennifer Li, Eric Sanchez, Michael Share, Jeffrey Steinberg, Ariana Berenson, Dror Shalitin, Zhaohui Zeng, Dorina Gui, Pablo Perez-Pinera, Ronald J. Berenson, Jonathan Said, Benjamin Bonavida, Thomas F. Deuel, James R. Berenson

Blood (2009) 113 (9): 1992–2002.

https://doi.org/10.1182/blood-2008-02-133751

Published: 2009

Journal Articles

A Novel Targeted Therapeutic Approach to Multiple Myeloma Using Tumor Specific Anti-Sense RNA Sequences

Zhi-Wei Li, PhD, Dror Shalitin, PhD, Jing Shen, Michael Share, Mingjie Li, Cathy S Wang, Eric Sanchez, Jeffrey A Steinberg, Haiming Chen, MD, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2008) 112 (11): 2727.

https://doi.org/10.1182/blood.V112.11.2727.2727

Published: 2008

Journal Articles

Blockage of TRAF6 Signaling Inhibits Osteoclast Formation and Tumor Cell through Blocking the NF-kB and JNK Pathways in Multiple Myeloma.

Haiming Chen, MD, PhD, Mingjie Li, Jennifer Li, Richard A. Campbell, Cathy S. Wang, Eric Sanchez, Jeffrey Steinberg, Michael Share, Dror Shalitin, PhD, James Wang, Shi-Jason Xie, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2007) 110 (11): 2511.

https://doi.org/10.1182/blood.V110.11.2511.2511

Published: 2007

Journal Articles

Wnt/β-Catenin Signaling Is Essential for the Transdifferentiation of Monocytes into Endothelial Cells by mCSF and Pleiotrophin.

Haiming Chen, MD, PhD, Mingjie Li, Richard Campbell, Cathy S. Wang, Jennifer Li, Eric Sanchez, Jeffrey Steinberg, Michael Share, Dror Shalitin, PhD, James Wang, Shi-Jason Xie, Yunchao Chang, PhD, Benjamin Bonavida, PhD, Thomas F. Deuel, MD, James R. Berenson, MD

Blood (2007) 110 (11): 1512.

https://doi.org/10.1182/blood.V110.11.1512.1512

Published: 2007

Journal Articles

Zoledronic Acid Suppresses Vasculogenesis: A New Effect of Bisphosphonates.

Haiming Chen, MD, PhD, Cathy S. Wang, Jennifer Li, Richard A. Campbell, Mingjie Li, Eric Sanchez, Jeffrey Steinberg, Michael Share, Dror Shalitin, PhD, James Wang, Shi-Jason Xie, Yunchao Chang, MD, Benjamin Bonavida, PhD, Thomas F. Deuel, MD, James R. Berenson, MD

Blood (2007) 110 (11): 3913.

https://doi.org/10.1182/blood.V110.11.3913.3913

Published: 2007

Journal Articles

The Novel Potent Pan-Deacetylase (DAC) Inhibitor, Panobinostat (LBH589), Markedly Enhances the Anti-Myeloma Effects of Chemotherapy In Vitro and In Vivo .

Richard A. Campbell, BS, Eric Sanchez, BA, Jeffrey Steinberg, BS, Michael Share, BA, Joseph Wang, Mingjie Li, Haiming Chen, MD, PhD, Dror Shalitin, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2007) 110 (11): 2520.

https://doi.org/10.1182/blood.V110.11.2520.2520

Published: 2007

Journal Articles

The Combination of the mTOR Inhibitor Rapamycin and Protein Kinase C Inhibitors Produces Marked Synergistic Anti-Myeloma Effects.

Dror Shalitin, PhD, Michael Share, BA, Richard A. Campbell, BS, Jeffrey Steinberg, BS, Eric Sanchez, BA, Joseph Wang, Richard Leuchter, Mingjie Li, Cathy S. Wang, BS, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2007) 110 (11): 4800.

https://doi.org/10.1182/blood.V110.11.4800.4800

Published: 2007

Journal Articles

The mTOR Inhibitor RAD001 (Everolimus) Inhibits Myeloma Tumor Growth In Vivo and Enhances the Anti-MM Effects of Bortezomib and Arsenic Trioxide.

Richard A. Campbell, BS, Eric Sanchez, BA, Jeffrey Steinberg, BS, Michael Share, BA, Joseph Wang, Mingjie Li, Richard Leuchter, Haiming Chen, MD, PhD, Dror Shalitin, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2007) 110 (11): 4801.

https://doi.org/10.1182/blood.V110.11.4801.4801

Published: 2007

Journal Articles

An Anti-VEGF Antibody, in Combination with Bortezomib, Markedly Inhibits Tumor Growth in SCID-hu Models of Human Multiple Myeloma.

Blood (2007) 110 (11): 4802.

https://doi.org/10.1182/blood.V110.11.4802.4802

Published: 2007

NARROW

Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis

A Novel Targeted Therapeutic Approach to Multiple Myeloma Using Tumor Specific Anti-Sense RNA Sequences

Blockage of TRAF6 Signaling Inhibits Osteoclast Formation and Tumor Cell through Blocking the NF-kB and JNK Pathways in Multiple Myeloma.

Wnt/β-Catenin Signaling Is Essential for the Transdifferentiation of Monocytes into Endothelial Cells by mCSF and Pleiotrophin.

Zoledronic Acid Suppresses Vasculogenesis: A New Effect of Bisphosphonates.

The Novel Potent Pan-Deacetylase (DAC) Inhibitor, Panobinostat (LBH589), Markedly Enhances the Anti-Myeloma Effects of Chemotherapy In Vitro and In Vivo .

The Combination of the mTOR Inhibitor Rapamycin and Protein Kinase C Inhibitors Produces Marked Synergistic Anti-Myeloma Effects.

The mTOR Inhibitor RAD001 (Everolimus) Inhibits Myeloma Tumor Growth In Vivo and Enhances the Anti-MM Effects of Bortezomib and Arsenic Trioxide.

An Anti-VEGF Antibody, in Combination with Bortezomib, Markedly Inhibits Tumor Growth in SCID-hu Models of Human Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only